These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39180207)

  • 1. FTO-Mediated m6A Modification of FTH1 Inhibits Ferroptosis of Neurons in Neonatal Cerebral Hypoxic Ischemia.
    Chen Y; Huang J
    Crit Rev Eukaryot Gene Expr; 2024; 34(8):47-57. PubMed ID: 39180207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat mass and obesity associated protein inhibits neuronal ferroptosis via the FYN/Drp1 axis and alleviate cerebral ischemia/reperfusion injury.
    Zhang Y; Gong X
    CNS Neurosci Ther; 2024 Mar; 30(3):e14636. PubMed ID: 38430221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
    Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
    J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO mediates the diabetic kidney disease progression through regulating the m
    Li Q; Mu S
    BMC Nephrol; 2024 Oct; 25(1):345. PubMed ID: 39390397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
    Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
    J Diabetes Complications; 2024 Aug; 38(8):108801. PubMed ID: 38935979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
    Hou L; Li S; Li S; Wang R; Zhao M; Liu X
    J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine demethylase FTO regulates synaptic and cognitive impairment by destabilizing PTEN mRNA in hypoxic-ischemic neonatal rats.
    Deng J; Liao Y; Chen J; Chen A; Wu S; Huang Y; Qian H; Gao F; Wu G; Chen Y; Chen X; Zheng X
    Cell Death Dis; 2023 Dec; 14(12):820. PubMed ID: 38092760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of USP18-Mediated NCOA4 m6A Modification Via Maintaining FTO Stability In Regulating Ferritinophagy-Mediated Ferroptosis in Cerebral Ischemia-Reperfusion Injury.
    Zhang Z; Zheng Z; Chen Y; Niu X; Ouyang T; Wang D
    Mol Neurobiol; 2024 Sep; ():. PubMed ID: 39331352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTPRC Inhibits Ferroptosis of Osteosarcoma Cells via Blocking TFEB/FTH1 Signaling.
    Shao Y; Zuo X
    Mol Biotechnol; 2024 Oct; 66(10):2985-2994. PubMed ID: 37851191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine Demethylase FTO Induces the Dysfunctions of Ovarian Granulosa Cells by Upregulating Flotillin 2.
    Zhou L; Han X; Li W; Wang N; Yao L; Zhao Y; Zhang L
    Reprod Sci; 2022 Apr; 29(4):1305-1315. PubMed ID: 34254281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of FTO inhibits oxidative stress to relieve neuropathic pain by m6A modification of GPR177.
    Liu L; Liu M; Song Z; Zhang H
    Immun Inflamm Dis; 2024 Jul; 12(7):e1345. PubMed ID: 39023405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
    Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
    Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.